The purpose of the clinical trial for Embrace and the Alert app is to demonstrate how effective they are in seizure detection and alerting caregivers in real-world conditions. It’s necessary to test on a large number of people to ensure that any benefit derived from the Embrace is not random, but occurs for many people. It’s overseen by a review board which protects the participants by monitoring the trial.
Our goal is to produce objective evidence that our seizure detection algorithm and alerting system facilitates intervention, and helps patients with tonic-clonic seizures regain independence. We also hope to further the understanding of epilepsy, and obtain useful data for epilepsy management.
If you are interested in participating, please visit How can I join the clinical trial?